Healthcare giant Johnson & Johnson is injecting data science across its business to improve its manufacturing, clinical trial enrollment, forecasting and more. “I actually like to call it decision science,” said Jim Swanson, the company’s executive vice president and enterprise chief information officer, in a panel discussion at the most recent NVIDIA GPU Technology Conference. Read article >
The post Down to a Science: How Johnson & Johnson Boosts Its Business With MLOps appeared first on The Official NVIDIA Blog.